NCT01237860View on ClinicalTrials.gov

Evaluation of the Safety and Performance of the NESS L300 Plus System

PHASE3CompletedINTERVENTIONAL

Enrollment

45

Participants

Timeline

Start Date

September 30, 2010

Primary Completion Date

January 31, 2011

Study Completion Date

January 31, 2011

Conditions

Foot DropThigh Muscles Weakness (Hamstrings or Quadriceps)Upper Motor Neuron Injury or Disease

Interventions

DEVICE

NESS L300 Plus System

The patients will receive the device for daily use of six (6) weeks.

Trial Locations (1)

Unknown

Reuth Medical Center, Tel Aviv

Sponsors

Lead Sponsor

Collaborators (1)

Bioness Neuromodulation

All Listed Sponsors

collaborator

Bioness Neuromodulation

INDUSTRY

lead

Bioness Inc

INDUSTRY

NCT01237860 - Evaluation of the Safety and Performance of the NESS L300 Plus System | Biotech Hunter | Biotech Hunter